Pathologist and Prognosis in Colorectal Cancer Surgery. - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Pathologist and Prognosis in Colorectal Cancer Surgery.

Description:

Pathologist and Prognosis in Colorectal Cancer Surgery. Dr Bryan F Warren Consultant Gastrointestinal Pathologist Oxford M62 Course 2004 Pathology of the formal ... – PowerPoint PPT presentation

Number of Views:254
Avg rating:3.0/5.0
Slides: 35
Provided by: macklinOr
Category:

less

Transcript and Presenter's Notes

Title: Pathologist and Prognosis in Colorectal Cancer Surgery.


1
Pathologist and Prognosis in Colorectal Cancer
Surgery.
  • Dr Bryan F Warren
  • Consultant Gastrointestinal Pathologist
  • Oxford
  • M62 Course 2004

2
Pathology of the formal colorectal cancer
resection specimen.
  • Staging and prognosis
  • What is the significance of theradial margin?
  • How should I look for lymph nodes?
  • What is a bad Dukes B cancer?

3
  • Cuthbert E Dukes
  • Consultant PathologistSt Marks Hospital
  • 1926-1956

4
Evolution of pathological staging.
  • UICC TNM 6th Edition 2002
  • Major changes or minor changes?
  • Likely that RCPath will recommend staying with
    TNM 5th edition.

5
Reproduced from Schiller KFR, Cockel R, Hunt RH,
Warren BF 2001.
6
Rectal cancer-How I do it
  • The specimen is received fresh, and inspected by
    me /- surgeon
  • /- trainee pathologists and surgeons.
  • I/we inspect
  • Mesorectal margin
  • Close distal margin
  • Tumour on peritoneal surface/mesorectal margin

7
(No Transcript)
8
Mesorectal margin and local recurrence in rectal
cancer
  • Quirke P, Durdey P, Dixon MF, Williams NS. Local
    recurrence of rectal adenocarcinoma
  • due to inadequate surgical resection.
    Histopathological study of lateral tumour spread
    and
  • surgical excision Lancet 19868514996
  • 14/52 LRM
  • 12/14 local recurrence
  • Specificity 92
  • Sensitivity 95
  • Positive predictive value 85

9
How many slices for histology?
10
How many slices for histology?
  • Quirke P, Durdey P, Dixon MF, Williams NS. Local
    recurrence of rectal adenocarcinoma
  • due to inadequate surgical resection.
    Histopathological study of lateral tumour spread
    and
  • surgical excision Lancet 19868514996
  • Single slice chosen macroscopically
  • 6/52 (12) LRM
  • On embedding and sectioning the whole tumour
    using large blocks
  • (10u HE stained sections cut on a sledge
    microtome)
  • 14/52 (27) LRM

11
  • Adam IJ, Mohamdee MO, Martin IG, Scott NA, Finan
    PJ, Johnston D, Dixon MF,
  • Quirke P. Role of circumferential margin
    involvement in the local recurrence of
  • rectal cancer. Lancet 1994 344(8924)707-711.
  • 190 patients
  • CRM in 25(35/141) potentially curative
    resections
  • CRM in 36(69/190) of all cases
  • Local recurrence after potentially curative
    resection in 25
  • CRM independently influenced both local
    recurrence and
  • survival
  • Confirms the need to examine CRM carefully

12
  • Hall NR, Finan PJ, Al-Jaberi T, Tsang CS, Brown
    SR, Dixon MF, Quirke P. Circumferential
  • margin involvement after mesorectal excision of
    rectal cancer with curative intent. Predictor
  • of survival but not local recurrence? Dis Colon
    Rectum 1998979-983.
  • 218 patients
  • 152 potentially curative resections.
  • 20 (13) tumour within 1mm CRM
  • 50 disease recurrence CRM at 41 months
  • Local recurrence in 15
  • 24 disease recurrence CRM- at 41 months
  • Local recurrence in 11(p0.38)
  • Disease free survival (p0.01) and mortality
    (p0.005) were related to CRM
  • Patients with an involved CRM may die of distant
    disease before local recurrence is apparent.

13
  • Birbeck KF, Macklin CP, Tiffin NJ, Parsons W,
    Dixon MF, Mapstone NP,
  • Abbott CR, Scott NA, Finan PJ, Johnston D, Quirke
    P. Rates of circumferential
  • resection margin involvement vary between
    surgeons and predict outcomes in
  • rectal cancer surgery. Ann Surg
    2002235449-457.
  • 608 patients 1986-1997
  • 586 clinical follow up available
  • 105 (17.9) developed local recurrence
  • 165 CRM positive 38.2 local recurrence
  • 421 CRM negative 10 local recurrence.
  • CRM had improved (75) 5 year survival over
    CRM (29)
  • CRM immediate post surgical predictor of
    survival (CR07)
  • Useful indicator of the quality of surgery-Audit

14
Pathologists assessment of the mesorectum
macroscopically.
  • Nagtegaal ID, van de Velde CJ, van der Worp E,
    Kapiteijn E, Quirke P, van Krieken JH
  • Cooperative Clinical Investigators of the Dutch
    Colorectal Cancer Group. Macroscopic
  • evaluation of rectal cancer resection specimen
    clinical significance of the pathologist in
  • quality control. J Clin Oncol 2002 20 1714-5.
  • 180 patients
  • 24 (43) incomplete mesorectum
  • 36.1 local and distant recurrence vs 20.3 in
    the group with a complete mesorectum
  • 2mm margin
  • Survival is predicted by proper assessment of the
    mesorectum, and judgement of the quality of TME.

15
Trials CR07 quality of surgery
P Quirke et al
16
Mode of CRM involvement
  • Birbeck et al
  • 6 types of CRM involvement
  • Direct tumour spread 46 pts 52.17 local
    recurrence
  • Discontinuous tumour spread 110pts 45
  • Tumour within a lymph node 19pts 10.53(caution
    pt. no. small)
  • Tumour within a blood vessel 23pts 30.43
  • Tumour within lymphatics 14pts 71.43
  • Perineural tumour 11pts 54.55

17
Lymph nodes
  • Find all that are there
  • Three contributors to lymph node numbers
    patient, surgeon and pathologist
  • Sampling method must not compromise assessment of
    CRM
  • Fat clearance? or
  • 30 minutes, hard seat, bright light, sharp knife?

18
  • Serosal Involvement in Colon Cancer
  • found in 242/412 (58.7)
  • most powerful independent prognostic marker
    (greater than extent of spread or LN
    involvement)
  • present in 45/46 patients who developed
    intraperitoneal recurrence
  • present in all 6 patients who developed pelvic
    recurrence
  • Shepherd et al 1997

19
  • Serosal Involvement in Rectal Cancer
  • anterior and lateral walls of mid and upper
    rectum
  • found in 54/209 (25.8)
  • independent prognostic marker
  • in 12 cases of local recurrence following
    complete resection (CRM-), 6 had LPI
  • Shepherd et al 1995

20
(No Transcript)
21
  • Prognosis in Dukes B Colonic Carcinoma
  • 268 cases, continuous, unselected
  • Single pathologist (mean LNs 21, tumour blocks
    5.7)
  • 5 year survival rate 76 (95 CI 70-81)
  • Logrank Cox multivariate regression analysis
  • Serosal involvement
  • Venous invasion (intramural or extramural)
  • Circumferential Margin involvement
  • Tumour perforation

22
  • Prognosis in Dukes B Colonic Carcinoma
  • Serosal involvement 1
  • Venous invasion (intramural or 1extramural)
  • Circumferential margin involvement (or inflamed
    in association with tumour) 1
  • Tumour perforation 2
  • HIGH RISK 2 or more

23
(No Transcript)
24
  • Non-peritonealised circumferential margin
    involvement in colon cancer
  • Regions of the colon where a significant
    proportion of the circumference is
    retroperitoneal
  • caecum
  • ascending colon
  • descending colon
  • distal sigmoid

25
(No Transcript)
26
(No Transcript)
27
Right hemicolectomy specimen
28
  • Retroperitoneal Margin Involvement in Caecal
    Cancer
  • 37 right hemicolectomies
  • Retroperitoneal surgical margin involved in 4/37
    (11)
  • Local recurrence approximately 10
  • Bateman Warren 2001

29
Guidelines
  • Changes
  • (Courtesy of Professor GT Williams)
  • Highlight the features that are of therapeutic
    importance
  • Clarify the definitions of important prognostic
    features and conventions for TNM staging
  • Include recommendations for reporting local
    excisions
  • Streamline the proforma

30
  • Features of Therapeutic Importance
  • Tumour perforation
  • Lymph node metastases
  • Circumferential margin positivity (rectal cancer)
  • Serosal involvement
  • Extramural vascular invasion
  • Poor differentiation

31
Problems with regression
  • Complete or partial
  • Quantitation if partial
  • Significance of mucus pools
  • Poor relationship to TNM stage

32
Rectal Cancer Regression Grade
1 Tumour sterilised or only microscopic
foci, marked fibrosis 2 Marked fibrosis with
macroscopic tumour 3 Little or no fibrosis,
abundant macroscopic disease Wheeler et al
Dis Colon Rectum 2002451051-6
33
  • Change
  • Multidisciplinary teams
  • Sub-specialisation
  • Improved preoperative staging (MRI)
  • Better surgery for rectal cancer
  • Better evidence for the efficacy of adjuvant and
    neoadjuvant chemotherapy and radiotherapy

34
Summary
  • The pathologist and prognosis in colorectal
    cancer surgery
  • To stage the tumour accurately
  • To assess the surgical margins of the resected
    specimen accurately
  • To assess the quality of the surgery
  • To sample lymph nodes adequately
  • To be aware of features of a bad Dukes B tumour
  • To communicate effectively with the
    multidisciplinary team
Write a Comment
User Comments (0)
About PowerShow.com